· Original article
Nike stock rebounds 16% as turnaround faces revenue test
Nike stock enters October 19–23 above its recent low, but falling sales, restructuring costs and a negative credit outlook test the recovery.
FINANCEVELIX / News
Equities & companies · Page 258
Equities & companies
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
My news topics
My news topics →Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 4,005 · Page 258 / 334
· Original article
Align patent ruling targets Angelalign’s Torque Ridges
Align patent ruling finds Angelalign’s Torque Ridges infringes a European patent, but Angelalign says a replacement already supports European customers.
· Original article
HDFC Bank leadership: Bagchi signals continuity before handover
HDFC Bank leadership prepares to change on October 27, 2026, as Anup Bagchi prioritizes understanding the bank and completing post-merger work.
· Original article
AIsa funding tops $9 million as Tether and HIVEN invest
AIsa funding exceeded $9 million after a seed extension backed by Tether and HIVEN, supporting enterprise AI tools and controlled automated payments.
· Original article
FCNR deposits squeeze margins at India's large private banks
FCNR deposits weighed on September 2026 margins at Axis, ICICI and HDFC Bank as funding costs and low-yielding lending offset balance-sheet growth.
· Original article
Magic state cultivation cuts errors in Google's Willow test
Google's magic state cultivation test cut errors about 40-fold on Willow, advancing quantum computing research while larger-scale demonstrations remain.
· Original article
Casdatifan data set for Arcus investor event on October 20
Arcus plans to present casdatifan data on October 20, 2026, covering kidney cancer treatment combinations and monotherapy ahead of Phase 3 milestones.
· Original article
Azenosertib survival data show 15.8 months in ovarian cancer subgroup
Azenosertib survival data show a 15.8-month median in Cyclin E1-positive ovarian cancer patients, with further trials needed to establish benefit.
· Original article
Crown earnings preview: Q3 release set for October 19
Crown earnings were due October 19, 2026, with analysts expecting modest profit growth and stronger revenue ahead of the packaging company's results.
· Original article
Steel Dynamics earnings due October 19 as forecasts top guidance
Steel Dynamics earnings are due October 19, with analysts expecting $5.40 per share, slightly above management’s third-quarter guidance.
· Original article
FNB earnings rise as bank repurchases $51 million in shares
FNB earnings reached $0.43 per share in Q3 2026 as interest income rose. The bank repurchased $51 million in shares, while fee income declined.
· Original article
Zions earnings preview: Q3 report due October 19, 2026
Zions earnings are due October 19, 2026, with analysts expecting higher profit and revenue. Dividend coverage is another focus ahead of the report.
Charts and market data by TradingView. Availability and delays vary by exchange.